Sanofi (SNY) EBIT Margin (2009 - 2026)
Sanofi (SNY) recorded EBIT Margin of 20.57% in Q3 2026, down 8.57 percentage points from 29.14% a year earlier but up 11.54 percentage points from the prior quarter.
Sanofi (SNY) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Sanofi's EBIT Margin came in at 20.26% as of Sep 30, 2026, up 7.22 percentage points year-over-year; for FY2025, it came in at 14.54%, down 3.11 percentage points from FY2024.
- Annual EBIT Margin has declined for three straight years, with a five-year change of -24.62 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at 17.65% in FY2024 (-0.75 pp), 18.40% in FY2023 (-8.59 pp), 26.99% in FY2022 (+5.47 pp) and 21.52% in FY2021 (-17.64 pp).
- Quarterly EBIT Margin has ranged from -10.11% in Q4 2023 to 38.26% in Q4 2022 over the past five years.
- On a year-over-year basis, EBIT Margin rose in four of the last seven quarters, with an average year-over-year change of +1.37 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 23.51 percentage points in Q4 2022, against a drop of 48.37 percentage points in Q4 2023 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,289.41 Bn | 1,263.02 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 687.33 Bn | 607.19 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 524.88 Bn | 492.89 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 361.94 Bn | 324.89 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 313.59 Bn | 286.83 Bn | - | - |
| 6 | Astrazeneca | 287.15 Bn | 260.67 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 253.53 Bn | 205.18 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.46 Bn | 185.57 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.39 Bn | 112.74 Bn | 12.56 Bn | 32.98% |
| 10 | Sanofi | 59.45 Bn | 29.65 Bn | 33.35 Bn | 20.57% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.57% |
| Jun 30, 2026 | 9.03% |
| Mar 31, 2026 | 20.18% |
| Sep 30, 2025 | 29.14% |
| Jun 30, 2025 | 4.56% |
| Mar 31, 2025 | 23.09% |
| Dec 31, 2024 | 8.91% |
| Sep 30, 2024 | 29.11% |
| Jun 30, 2024 | 16.25% |
| Mar 31, 2024 | 13.84% |
| Dec 31, 2023 | -10.11% |
| Sep 30, 2023 | 26.84% |
| Jun 30, 2023 | 18.66% |
| Mar 31, 2023 | 24.10% |
| Dec 31, 2022 | 38.26% |
| Sep 30, 2022 | 21.82% |
| Jun 30, 2022 | 14.16% |
| Mar 31, 2022 | 24.78% |
| Dec 31, 2021 | 14.75% |
| Sep 30, 2021 | 29.06% |
Sanofi EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();